Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachida Bouamar

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Therapeutic Drug Monitoring|June 24, 2010
The pharmacogenetics of calcineurin inhibitor-related nephrotoxicityDennis A Hesselink, Rachida Bouamar, Teun van Gelder
NDT Plus|May 8, 2015
Polymorphisms of the glucocorticoid receptor and avascular necrosis of the femoral heads after treatment with corticosteroidsRachida Bouamar, Jan Willem Koper, Elisabeth F C van Rossum, et al.
International Journal of Medical Informatics|February 13, 2010
Functionality test for drug safety alerting in computerized physician order entry systemsHeleen van der Sijs, Rachida Bouamar, Teun van Gelder, et al.
Clinical Pharmacokinetics|November 20, 2013
The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantationDennis A Hesselink, Rachida Bouamar, Laure Elens, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 2011
ATP-binding cassette transporters as pharmacogenetic biomarkers for kidney transplantationNauras Shuker, Rachida Bouamar, Willem Weimar, et al.
Pharmacogenetics and Genomics|March 6, 2012
The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patientsLaure Elens, Rachida Bouamar, Dennis A Hesselink, et al.
British Journal of Clinical Pharmacology|October 15, 2013
Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocksLaure Elens, Rachida Bouamar, Nauras Shuker, et al.
Transplantation|May 11, 2012
Mycophenolic acid-related anemia and leucopenia in renal transplant recipients are related to genetic polymorphisms in CYP2C8Rachida Bouamar, Laure Elens, Nauras Shuker, et al.
Therapeutic Drug Monitoring|May 14, 2011
CYP3A5 genotype is not related to the intrapatient variability of tacrolimus clearanceNilufar Pashaee, Rachida Bouamar, Dennis A Hesselink, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|October 4, 2017
Intrapatient Variability in Tacrolimus Exposure Does Not Predict The Development of Cardiac Allograft Vasculopathy After Heart TransplantNauras Shuker, Rachida Bouamar, Dennis A Hesselink, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Therapeutic Drug Monitoring|June 24, 2010
The pharmacogenetics of calcineurin inhibitor-related nephrotoxicityDennis A Hesselink, Rachida Bouamar, Teun van Gelder
NDT Plus|May 8, 2015
Polymorphisms of the glucocorticoid receptor and avascular necrosis of the femoral heads after treatment with corticosteroidsRachida Bouamar, Jan Willem Koper, Elisabeth F C van Rossum, et al.
International Journal of Medical Informatics|February 13, 2010
Functionality test for drug safety alerting in computerized physician order entry systemsHeleen van der Sijs, Rachida Bouamar, Teun van Gelder, et al.
Clinical Pharmacokinetics|November 20, 2013
The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantationDennis A Hesselink, Rachida Bouamar, Laure Elens, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 15, 2011
ATP-binding cassette transporters as pharmacogenetic biomarkers for kidney transplantationNauras Shuker, Rachida Bouamar, Willem Weimar, et al.
Pharmacogenetics and Genomics|March 6, 2012
The new CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) is associated with an increased risk of delayed graft function and worse renal function in cyclosporine-treated kidney transplant patientsLaure Elens, Rachida Bouamar, Dennis A Hesselink, et al.
British Journal of Clinical Pharmacology|October 15, 2013
Clinical implementation of pharmacogenetics in kidney transplantation: calcineurin inhibitors in the starting blocksLaure Elens, Rachida Bouamar, Nauras Shuker, et al.
Transplantation|May 11, 2012
Mycophenolic acid-related anemia and leucopenia in renal transplant recipients are related to genetic polymorphisms in CYP2C8Rachida Bouamar, Laure Elens, Nauras Shuker, et al.
Therapeutic Drug Monitoring|May 14, 2011
CYP3A5 genotype is not related to the intrapatient variability of tacrolimus clearanceNilufar Pashaee, Rachida Bouamar, Dennis A Hesselink, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|October 4, 2017
Intrapatient Variability in Tacrolimus Exposure Does Not Predict The Development of Cardiac Allograft Vasculopathy After Heart TransplantNauras Shuker, Rachida Bouamar, Dennis A Hesselink, et al.
Pageof 2